Study group | Variable | Category | Parameter | Adjusted ORsa | 95% CI | P-values |
---|---|---|---|---|---|---|
Group A | Age | 10 years | −1.09 | 0.34 | 0.11–1.01 | 0.052 |
11 years | −1.00 | 0.37 | 0.11–1.20 | 0.098 | ||
12 years | −0.81 | 0.44 | 0.17–1.18 | 0.104 | ||
Sex | Male | 0.07 | 1.07 | 0.48–2.35 | 0.871 | |
Treatment | Biannual treatment | 0.58 | 1.79 | 0.1–33.42 | 0.698 | |
Group B | Age | 10 years | −0.17 | 0.84 | 0.69–1.03 | 0.090 |
11 years | −0.28 | 0.75 | 0.61–0.94 | 0.011 | ||
12 years | −0.48 | 0.62 | 0.5–0.77 | < 0.001 | ||
Sex | Male | 0.26 | 1.30 | 1.13–1.50 | < 0.001 | |
Treatment | Biannual treatment | −0.84 | 0.43 | 0.2–0.95 | 0.037 | |
Group C | Age | 10 years | 0.03 | 1.03 | 0.83–1.28 | 0.815 |
11 years | −0.17 | 0.84 | 0.65–1.08 | 0.178 | ||
12 years | −0.30 | 0.74 | 0.57–0.95 | 0.019 | ||
Sex | Male | 0.09 | 1.10 | 0.93–1.29 | 0.272 | |
Treatment | Biannual treatment | 0 | 1 | 0.43–2.33 | 0.999 |